National Framework Agreement for the supply of products for the management of Hereditary Angioedema
Hereditary Angioedema The purpose of this 'future opportunity' notice is to indicate that a live 'opportunity' may be published at a future date. However, any existing 'live' framework agreement may be subject to an extension up to the maximum extension period allowed.
Buyer
NHS ENGLAND
Value
£74,500,000
Published
5 Jul 2022
Closes
5 Jul 2022
Procurement details
Source
Contracts Finder
Region
United Kingdom
Procurement method
Open
Category
Goods
Contract starts
Not provided
Contract ends
Not provided
CPV classifications
33600000
Pharmaceutical products
Lots
Lot default National Framework Agreement for the supply of products for the management of Hereditary Angioedema
£74,500,000
Hereditary Angioedema The purpose of this 'future opportunity' notice is to indicate that a live 'opportunity' may be published at a future date. However, any existing 'live' framework agreement may be subject to an extension up to the maximum extension period allowed.
Delivery: England · United Kingdom, Guernsey, Isle of Man, Jersey, Northern Ireland · United Kingdom, Scotland · United Kingdom
Documents
Unlock document linkFuture opportunity notice on Contracts Finder
5 Jul 2022
Future opportunity notice on Contracts Finder
Planned procurement notice · Web page
Contains public sector information licensed under the Open Government Licence v3.0.